Spyre Therapeutics News

Spyre Therapeutics Initiated at Outperform by Wedbush

Dow JonesSep 4 11:36 ET

Spyre Therapeutics Analyst Ratings

BenzingaSep 4 11:26 ET

Wedbush Initiates Spyre Therapeutics(SYRE.US) With Buy Rating, Announces Target Price $45

Moomoo NewsSep 3 17:31 ET

Analysts' Top Healthcare Picks: PMV Pharmaceuticals (PMVP), Spyre Therapeutics (SYRE)

TipRanksAug 8 10:34 ET

TD Cowen Remains a Buy on Spyre Therapeutics (SYRE)

TipRanksAug 7 20:39 ET

Spyre Therapeutics Analyst Ratings

BenzingaJul 16 10:34 ET

Spyre Therapeutics Analyst Ratings

BenzingaMay 13 09:46 ET

Buy Rating Affirmed: Spyre Therapeutics' Promising Pipeline and Expert Team Drive Positive Outlook

TipRanksMay 10 12:50 ET

Spyre Therapeutics Analyst Ratings

BenzingaMay 10 10:54 ET

Spyre Therapeutics Analyst Ratings

BenzingaMay 2 05:07 ET

Buy Rating Affirmed for Spyre Therapeutics on Promising MAb Dosing and Market Positioning

TipRanksApr 5 08:01 ET

Stifel Adjusts Spyre Therapeutics' Price Target to $54 From $36, Maintains Buy Rating

MT NewswiresMar 26 10:38 ET

Spyre Therapeutics Analyst Ratings

BenzingaMar 26 06:11 ET

Strong Buy Rating for Spyre Therapeutics Based on Promising SPY001 Data and Financial Position

TipRanksMar 25 17:30 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (HUM), Alnylam Pharma (ALNY) and Spyre Therapeutics (SYRE)

TipRanksMar 6 06:15 ET

Spyre Therapeutics Analyst Ratings

BenzingaMar 1 11:08 ET

Analysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX), Madrigal Pharmaceuticals (MDGL) and Spyre Therapeutics (SYRE)

TipRanksMar 1 08:10 ET

Stifel Nicolaus Remains a Buy on Spyre Therapeutics (SYRE)

TipRanksMar 1 07:49 ET

Buy Rating for Spyre Therapeutics: Anticipated Clinical Trials and Strategic Advantages Propel Optimism

TipRanksMar 1 06:55 ET

TD Cowen Sticks to Its Buy Rating for Spyre Therapeutics (SYRE)

TipRanksFeb 29 23:25 ET